New Relic, Inc.
(NEWR)
Monteverde & Associates Announces the Investigation of New Relic, Inc.
Denbury, Inc.
(DEN)
Monteverde & Associates Announces the Investigation of Denbury, Inc.
Frequency Therapeutics, Inc.
(FREQ)
Monteverde & Associates Announces the Investigation of Frequency Therapeutics, Inc.
Heritage-Crystal Clean, Inc.
(HCCI)
Monteverde & Associates Announces the Investigation of Heritage-Crystal Clean, Inc.
Neoleukin Therapeutics, Inc.
Monteverde & Associates Announces the Investigation of Neoleukin Therapeutics, Inc.
Sculptor Capital Management Inc.
(SCU)
Monteverde & Associates Announces the Investigation of Sculptor Capital Management Inc.
Pardes Biosciences, Inc
(PRDS)
Monteverde & Associates Announces the Investigation of Pardes Biosciences, Inc
Sigilon Therapeutics, Inc.
(SGTX)
Monteverde & Associates Announces the Investigation of Sigilon Therapeutics, Inc.
Immunome, Inc.
(IMNM)
Monteverde & Associates Announces the Investigation of Immunome, Inc.
Great Ajax Corp.
(AJX)
Monteverde & Associates Announces the Investigation of Great Ajax Corp.
American Equity Investment Life Holding Co.
(AEL)
Monteverde & Associates Announces the Investigation of American Equity Investment Life Holding Co.
Western Asset Mortgage Capital Corp.
(WMC)
Monteverde & Associates Announces the Investigation of Western Asset Mortgage Capital Corp.
Conformis, Inc.
(CFMS)
Monteverde & Associates Announces the Investigation of Conformis, Inc.
